2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$0.99-$0.002 (-0.21%)
Price as of Nov 12, 2026 8:12 AM EST- $26.5MMarket Cap
- -66.82%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$0.99-$0.002 (-0.21%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | +$0.002 (+0.21%) | ||
Open | $0.99 | ||
High | $1.07 | ||
Low | $0.98 | ||
Previous Close | $0.99 | ||
Volume | 5,648 | ||
30-Day Average Volume | 39,837 | ||
1-Week Change | -0.79% | ||
1-Month Change | -0.79% | ||
1-Year Change | -66.82% | ||
3-Year Change | -6.41% | ||
5-Year Change | -97.10% | ||
Fundamentals | |||
Shares Outstanding | 26.7M | ||
Total Assets | $20.3M | ||
Market Cap | $26.5M | ||
Enterprise Value | $26.9M | ||
Period: QTR TTM FY | |||
Revenue | -$7,485.00 | ||
Net Income | $1.1M | ||
Free Cash Flow | -$438,911.00 | ||
EBIT | $1.1M | ||
EBITDA | $1.2M | ||
Net Working Capital | -$5.8M | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 23 | ||
Enterprise Value/Revenue | -3,589 | ||
P/B | 2 | ||
P/E | 25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -60 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue